Compounded "semaglutide" is not FDA approved semaglutide.com The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA takes first step in possible reversal of ban on some peptides The Washington Post BPC 157: Experimental Peptide Creates Risk for Athletes Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law Is BPC 157 Legal? Understanding Its Status and Implications